CD34 and acute myeloid leukemia: Considering that RUNX3 is frequently overexpressed in AML, we next examined the impact of RUNX3 overexpression on myeloid development by transducing normal human CD34+ HSPC with recombinant retrovirus co-expressing RUNX3 and DsRed.